Procurement for Lots No. 2; 4, 9, 12, 13, 15, 17, 20, 22, 25, 33, 34, 35, 36, 37, 38, 39

This tender concerns the procurement of specific pharmaceutical products, primarily oncology medications, divided into several distinct lots. The contracting authority is seeking to acquire a range of targeted therapies and chemotherapeutic agents essential for patient treatment. Key items include Panitumumab Vectibix (L01FE02) for infusion, Nintedanib Vargatef (L01EX09) capsules, and Lapatinib Tyverb (L01EH01) tablets, all in specified dosages and quantities. The tender also covers other critical medications such as Vandetanib Caprelsa (L01XE12), Afatinib Giotrif (L01EB03), Crizotinib Xalkori (L01ED01), Dabrafenib Tafinlar (L01EC02), Olaparib Lynparza (L01XK01), Alpelisib Piqray (L01EM03), Brigatinib Alunbrig (L01XE43), Talazoparib Talzenna (L01XK04), Osimertinib Tagrisso (L01EB04), Ribociclib Kisqali (L01XE42), Palbociclib Ibrance (L01EF01), Abemaciclib Verzenios (L01EF03), Trametinib Mekinist (L01EE01), and Regorafenib Stivarga (L01EX05). The procurement is structured into multiple lots, indicated by the numbers provided, suggesting that bidders may be able to tender for one or more specific groups of products. Detailed specifications regarding the form of administration (e.g., concentrate for solution for infusion, soft capsule, film-coated tablet), dosage strength (mg), packaging (e.g., vial, blister, bottle), and total quantities required are listed for each medication. This procurement is crucial for ensuring the continuous supply of vital cancer treatments within the healthcare system.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and Medical Equipment. Located in Bulgaria, Europe, this opportunity is open to firms and consortiums, with an estimated budget of BGN 151,965.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.